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Abstract
Objective: Motivation is theorized to be a key determinant of behavior but has not been applied
to human papillomavirus (HPV) vaccination. Autonomous motivation is hypothesized to be the
most "self-determined" type of motivation and may contribute to parents' decisions to initiate and
complete the HPV vaccine series. I examined patterns of association between motivation types
and HPV vaccination as well as the pathways linking autonomous motivation with intentions to
vaccinate.
Methods: As part of a larger project, parents (N=177) of unvaccinated adolescents completed a
survey including a measure of parental motivation for adolescent vaccination. After 12 months, I
reviewed electronic medical records to obtain HPV vaccination coverage data. I used logistic
regression models to determine which motivation types—autonomous, introjected, or external—
were associated with one- and three-dose coverage. I examined ordinal regression models to
assess the overall effect of motivation on HPV vaccine coverage. Additionally, I tested
competing models of the direct effect of autonomous motivation and the indirect effect through
other psychosocial variables to determine which pathway(s) best explain the relationship
between autonomous motivation and intentions to vaccinate.
Results: Results indicate autonomous motivation is a significant predictor of 1-dose coverage
(OR = 2.47; 95%CI: [1.202, 5.079], p = .01) and of 3-dose coverage (OR = 2.68; 95%CI: [1. 00,
7.18], p = .05). Ordinal regression models confirmed greater autonomous motivation is
associated with increased likelihood of pursuing HPV vaccine coverage (OR = 2.452, 95% CI =
1.257 - 4.786, p = .009). There were no significant effects of introjected or external motivation
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on one- or three-dose coverage (ps > .142). Moreover, a model with both direct effects of
autonomous motivation on intentions and indirect effects via attitudes best fit the data.
Conclusions: Findings support the utility of distinguishing the type of underlying motivation for
adolescent HPV vaccination. Autonomous motivation, rather than introjected and external
motivation, was positively associated with one- and three-dose coverage. Thus, autonomysupportive interventions to promote parents’ beliefs that the HPV vaccine is important and
beneficial to their child's health may be a useful mechanism for increasing rates of completion of
the vaccine series.
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The Influence of Parental Autonomous Motivation on Adolescent HPV Vaccine Initiation and
Completion
Despite well-demonstrated benefits of vaccinating against human papillomavirus (HPV),
including protection against several types of cancer and genital warts, rates of adolescent vaccine
coverage remain low. Motivation is theorized to be a key determinant of behavior (Deci & Ryan;
1985), and research has demonstrated autonomous motivation—motivation due to the experience
of volition and belief in the value and importance of a behavior—facilitates behavior
performance and maintenance (Ryan & Deci, 2000). Accordingly, autonomous motivation may
be influential in decisions to receive the required three doses of the HPV vaccine. Autonomous
motivation, more than other types of controlled motivation, may contribute to parents’ decisions
to get the first dose of the vaccine as well as decisions to return for follow-up doses. The current
study tested the effects of motivation on HPV vaccine initiation and completion and explored the
pathways by which motivation might influence parents' decisions to vaccinate their children.
Since the inception of the HPV vaccine in 2006, vaccine initiation and completion rates
have been suboptimal. Although HPV is the leading cause of cervical cancer, anogenital cancer,
and genital warts (CDC, 2015), series initiation (65.1% for girls and 56% for boys) and
completion (49.5% for girls and 37.5% for boys) rates remain below the Healthy People 2020
goal of 80% three-dose coverage (Office of Disease Prevention and Health Promotion [ODPHP],
2016; Walker et al., 2017). The CDC (Walker et al., 2017) recommends the vaccine for girls and
boys ages 11 to 12 and catch-up vaccination for men up to age 21 and women up to age 26.
Previous guidelines were for all individuals to receive three doses of the vaccine. However, in
the fall of 2016, the Advisory Committee on Immunization Practice (ACIP) changed their
recommendation for individuals initiating the vaccine series before their 15th birthday to two
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doses received six months apart (Robinson et al., 2018). For individuals beginning the series on,
or after, their 15th birthday, the recommendation is to receive three doses of the vaccine (on a 0,
2-, and 6-month schedule; Robinson et al., 2018). Despite receipt of doctor’s recommendation,
many parents remain undecided about the HPV vaccine and fail to vaccinate their children.
Completion of the vaccine series is key to cancer prevention as partially vaccinated individuals
may not be entirely protected from HPV (Widdice et al., 2011), and factors impeding completion
must be clarified. Reviews of the literature have identified factors influencing vaccine initiation
(Bartlett & Peterson, 2011; Garcini et al., 2012; Kessels et al., 2012); however, predictors of
completion have been largely ignored (Holman et al., 2014). Self-Determination Theory (SDT)
suggests that behavior will be initiated and maintained if it is autonomously motivated (Deci &
Ryan, 1985, 2008). Concerning HPV vaccination, successful initiation and completion of the
vaccine series is theorized to result from personally valuing vaccination and its associated health
benefits (i.e., cancer and genital wart prevention). Thus, autonomous motivation may be an
influential factor in decisions to vaccinate.
Self-Determination Theory posits that motivation occurs along a continuum, from selfdetermined to controlled (Deci & Ryan; 1985; Deci & Ryan, 2008; Williams et al., 1996).
Autonomous motivation is considered to be the most “self-determined” form of motivation and
underlies behaviors performed because they are valued and believed to be important. Further,
autonomous motivation entails internalization of values. For example, an autonomously
motivated parent might get the HPV vaccine for their adolescent because it matches with an
overall goal of supporting their child’s health. External motivation underlies behaviors
performed due to outside pressures and is the most “controlled” type of motivation. External
motivation implies no internalization of beliefs and underlies behavior performed to gain a
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reward or avoid a punishment (Ryan et al., 2008; Williams et al., 1996; Williams et al., 2006). A
parent who vaccinated their adolescent to make their partner or their healthcare provider happy
would do so because of external motivation. In the middle of the spectrum, between autonomous
and external motivation, is introjected motivation. Introjected motivation is theorized to describe
partially internalized beliefs and values (Howard, Gagné, & Bureau, 2017; Ryan et al., 2008;
Williams et al., 1996; Williams et al., 2006). Behaviors inspired by introjected motivation are
performed to avoid a sense of guilt or shame. For example, a parent vaccinating their adolescent
to avoid feeling bad about himself/herself would do so because of introjected motivation. In the
context of HPV vaccination, one would expect parents who are autonomously motivated to
vaccinate their adolescents to be most likely to initiate the series.
Individuals who are autonomously motivated are more likely to perform health behaviors
(Deci & Ryan, 2008). The positive effect of autonomous motivation on health behavior
performance has been demonstrated across a wide variety of behaviors including physical
activity performance, weight loss, smoking cessation, and diabetes management (Kennedy,
Goggin, & Nollen, 2004; Williams et al., 1996; Williams et al., 2002). Theoretically, increased
identification with values will lead to an increased sense of personal volition (Deci & Ryan,
2008). In contrast, studies examining introjected and external motivation demonstrate neutral or
negative associations with health behaviors such as physical activity performance, weight loss,
and glycemic control (Edmunds, Ntoumanis, & Duda, 2006; Levesque et al., 2007; Standange,
Sebire, & Loney, 2008; Williams et al., 1996; Williams et al., 2002; Wilson, Rodgers, & Fraser,
2002; Wilson et al., 2003; Wilson et al., 2006). Taken together, findings from work in other
health domains suggest that differentiating between types of motivation may be beneficial for
promoting HPV vaccination.

AUTONOMOUS MOTIVATION AND HPV VACCINATION

7

Previous work examining HPV vaccination has identified several factors that are
associated with HPV vaccine initiation (Brewer et al., 2011; Fuchs et al., 2016; Gerend &
Shepherd, 2012; Thomas et al., 2012). Intentions, or plans to attain a behavioral goal,
significantly predict initiation of the HPV vaccine (Brewer et al., 2011; Gerend & Shepherd,
2012). Attitudes, or beliefs about the outcome of health-related behavior, are also related to
vaccine initiation, and this effect is proposed to occur through attitudes impact on intentions
(Ajzen, 1996; Bastani et al., 2011; Gerend & Shepherd, 2012). However, intentions do not
necessarily translate into behavior, and these variables leave a considerable amount of variance
in behavior unexplained (Hagger et al., 2002; Norman & Conner, 2005; Sheeran & Abraham,
2003).
Examining motivation can give insights into the reasons parents engage in behavior, so
motivation, theorized to be an antecedent to intentions (Hagger & Chatzisarantis, 2014), may
explain variance in decisions to vaccinate above and beyond parents' intentions. A parent may be
compelled to vaccinate their adolescent because they believe vaccination will be best for their
child's future health, to avoid feelings of guilt, or because they are seeking the approval of their
doctor. SDT, however, suggests that more self-determined forms of motivation are more likely
to lead to behavioral adoption than controlled types of motivation (Deci & Ryan, 2000). While
parents may be motivated to vaccinate their children for a variety of reasons, parents who
experience autonomous motivated may be more inclined to move forward with vaccination than
parents with greater introjected or external motivation (Deci & Ryan, 2000; Howard, Gagné, &
Bureau, 2017). While studies have examined the influence of motivation as it pertains to other
health behaviors (e.g., smoking cessation, weight loss), it has not been applied to studies of

AUTONOMOUS MOTIVATION AND HPV VACCINATION

8

vaccination behavior. Accordingly, autonomous motivation may hold promise in facilitating
decisions to initiate the vaccine series.
Despite an accumulation of studies examining predictors of vaccine initiation, a review of
the literature by Holman and colleagues (2014) found there is relatively little work exploring
predictors of vaccine completion. Researchers have, however, identified several barriers
impacting completion including forgetting, lacking awareness of the necessity of follow-up
doses, and being too busy to return to the clinic (Holman et al., 2014; Kouyoumdjian &
Bailowitz, 2011). Information on psychological factors that facilitate completion will allow us to
address suboptimal completion rates.
One factor that may contribute to low completion rates is differences in types of
motivation. For example, autonomous motivation may explain which parents return to obtain
follow up doses of the HPV vaccine to complete the series. Deci and Ryan (1985) suggested that
the distinction between self-determined and controlled motivation is of particular importance in
the prediction of the long-term maintenance of behavior. Several studies support the relationship
between autonomous motivation and maintenance of various health behaviors, such as weight
loss (Williams et al., 1996), smoking cessation (Williams & Deci, 1996; Williams et al., 2006),
and medication adherence (Williams et al., 2009). The effect of autonomous motivation on
behavior maintenance is also evident in HIV-medication adherence (Kennedy, Goggin, &
Nollen, 2004), glycemic control (Williams et al. 2004) and physical activity performance
(Kinnafick, Thøgersen-Ntoumani, & Duda, 2014; Wilson et al., 2006).
Autonomous rather than introjected and external motivation may be particularly salient in
the completion of the HPV vaccine series. Parents who have internalized the benefits of
vaccination and perceive themselves as having chosen to vaccinate their children because of
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these benefits (i.e., parents who are autonomously motivated) would be more likely to overcome
barriers to vaccination and receive the requisite follow-up doses. Successful completion of the
series would not result from introjected or external reasons for vaccination as an individual
vaccinating their child to avoid feelings of guilt, or to please their provider, has not personally
endorsed the behavior and feels no genuine willingness to maintain activities for vaccine
completion. Given these theoretical and empirical distinctions, the examination of the motivation
underlying vaccination may allow us to understand the decisions to pursue further doses of HPV
vaccination.
Though SDT provides useful explanations for the reasons people engage in a behavior, it
does not explain the processes by which motivation translates into behavior. Previous work has
suggested that having greater self-determined motivation can lead to the development of positive
attitudes and beliefs towards a behavior as well as higher perceived control, or competence
(Williams et al., 1996; Williams et al., 2006). This process is suggested to occur through the
internalization of beliefs whereby people are predisposed to form beliefs consistent with their
motivation (Hagger & Chatzisarantis, 2009). Attitudes towards behavior and perceived control,
or self-efficacy, both appear in the Theory of Planned Behavior (TPB, Ajzen, 1991). Thus,
incorporating autonomous motivation into the TPB may explain the process by which motivation
translates into behavior.
Hagger & Chatzisarantis (2009; 2014) proposed an integration of autonomous motivation
and TPB in the Integrated Behavior Change Model (IBC) that conceptualizes autonomous
motivation as a precursor to the belief-based predictors in TPB with indirect effects on intentions
and behavior. Hypothesized connections between belief-based constructs in TPB (i.e., attitudes,
self-efficacy, and norms) and self-determined motivation (i.e., that increased autonomous
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motivation leads to more positive attitudes and higher self-efficacy and thus, increased intentions
and behavior performance) support the integration of autonomous motivation into the TPB.
However, this integrated model and the purported indirect effects of autonomous motivation on
behavior via TPB variables have not been applied to HPV vaccination.
Clarifying the pathways through which autonomous motivation influences behavior
would facilitate the identification of psychological factors that are critical determinants of
vaccination. The IBC model (Hagger & Chatzisarantis, 2014) suggests an indirect effect of
autonomous motivation on both intentions to vaccinate and vaccine initiation through attitudes,
self-efficacy, and subjective norms. However, SDT suggests autonomous motivation directly
influences behavior. Additionally, there is evidence to suggest autonomous motivation may
contribute to the prediction of health behaviors over and above vaccine intentions and the
predictors included in the TPB (Ajzen, 1991; Hagger et al., 2002; McLachlan & Hagger, 2011).
Thus, the role and importance of autonomous motivation differ between the IBC model and
SDT. Previous work integrating autonomous motivation into the TPB has not compared the
potential role of autonomous motivation as a proximal or distal factor influencing behavior.
Brewer and Gilkey (2012) described two different methods of testing health behavior
theories: a summary approach and a competitive hypothesis testing approach. To test theories
using a summary approach, all predictors of two theories are measured, and the respective
overall model fit and variance explained are compared to determine which theory best predicts
the outcome. However, Brewer and Gilkey (2012) posit that use of a summary approach may be
less appropriate when considering that theories are often “cross-pollinated” and rarely applied as
initially proposed. Thus, they suggest an alternative, more flexible means of theory comparison:
competitive hypothesis testing. In competitive hypothesis testing, areas where two theories have
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differing explanations for associations between variables are identified and compared with the
data. Though not common in health behavior research, competitive hypothesis testing could
facilitate the identification of pathways critical to the application of theory to behavior (Brewer
& Gilkey, 2012). The role of autonomous motivation in predicting behavior differs across
theories. SDT argues that autonomous motivation directly influences behavior as a proximal
influence, while the IBC theory conceptualizes autonomous motivation as a distal factor that
affects behavior via its effect on attitudes, self-efficacy, norms, and intentions. Application of
competitive hypothesis testing, rather than a summary approach, allows for testing of the
alternative hypotheses by which autonomous motivation influences HPV vaccination.
Current Study
HPV vaccination rates remain suboptimal despite efforts to describe impediments and
design interventions to promote early vaccination. To date, SDT and motivation have not been
applied to the prediction of HPV vaccination. The present study aims to identify the effects of
different types of motivation on vaccination behavior and to describe the mechanisms by which
motivation may influence vaccination behavior among undecided parents. Autonomous
motivation shows significant promise in explaining reasons for vaccination and providing a
potential target for interventions to increase vaccine coverage.
The objectives of this study are 1) to examine the relationships between different types of
motivation and HPV vaccination initiation and completion, and 2) to test the pathways linking
autonomous motivation, vaccine initiation, and attitudes, norms, self-efficacy, and vaccine
intentions. I chose to focus on these variables because of previous work positing the integration
of autonomous motivation and the TPB (Hagger & Chatzisarantis, 2009; 2014). To determine
and quantify the effects of motivation on HPV vaccination initiation and completion, I conducted
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a secondary analysis of data from a larger study to design and test the effects of a tablet-based
intervention to promote HPV vaccination among undecided parents. I examined the influence of
motivation on two primary outcomes: one-dose coverage (i.e., receipt of one or more doses of
the vaccine), and three-dose coverage (i.e., receipt of three doses of the vaccine). I predicted that,
consistent with SDT and previous work in other domains, autonomous motivation would be a
stronger predictor of vaccination behavior than introjected and external motivation. In addition to
these outcomes, to determine the effect that the changed dosing recommendations by the ACIP
might have on the relationship between motivation and completion of the vaccine series, I
examined the influence of motivation on a broader definition of completion that included the
ACIP's new guidelines of receiving 2 doses over 6 months for individuals who began the vaccine
series before age 15— “up-to-date” coverage. To test the alternative explanations of the role of
autonomous motivation in influencing HPV vaccination proposed in SDT and the IBC model, I
compared models comprising the direct and indirect effects of autonomous motivation via
attitudes, norms, and self-efficacy on intentions to vaccinate and one-dose coverage. Explicitly, I
tested the following research questions and associated hypotheses:
RQ1.

To what extent do the three types of motivation (autonomous, introjected, and external)

predict HPV vaccine series initiation (i.e., one-dose coverage)?
a. I hypothesized that autonomous motivation would be a stronger predictor of HPV
vaccine initiation than introjected and external motivation.
RQ2. To what extent do the three types of motivation (autonomous, introjected, and external)
predict HPV vaccine series completion (i.e., three-dose coverage or up-to-date coverage)?
a. I hypothesized that autonomous motivation would be a stronger predictor of HPV
vaccine completion than introjected and external motivation.
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To test the competing pathways linking autonomous motivation to intentions to vaccinate and
HPV vaccination, I tested competing models (i.e., direct versus indirect pathways) to address the
questions:
RQ3.

Does autonomous motivation a) directly influence intentions to vaccinate or b) indirectly

influence intentions via attitudes, norms, and self-efficacy?
RQ4.

Does autonomous motivation a) directly influence one-dose coverage or b) indirectly

influence initiation via vaccine intentions?
Method
Data for the study was collected as part of the baseline survey of a multi-stage project to
develop and test a tablet-based self-persuasion intervention to promote HPV vaccination among
undecided parents (Baldwin et al., 2017; Shay et al., 2016; Tiro et al., 2016).
Participants
Demographics for parent participants and their adolescent are presented in Table 1.
Participants (N = 177) consisted of undecided parents of unvaccinated adolescents ages 11-17
identified through weekly electronic health record (EHR) reports identifying unvaccinated
adolescents. Of the 177 participants, 36.7% (N=65) initiated the vaccine series, and 15.3%
(N=27) received three doses by one-year follow-up. The number of individuals completing the
series increased when considering those who met criteria for completion based on ACIP
guidelines (N=3). The majority of the sample was female (97.2%), Spanish-speaking (58.8%),
and Hispanic (68.9%). The majority of adolescents were also Hispanic (67.2%), and there was a
nearly even split by adolescent sex (52.5% male). Parkland is a safety-net hospital serving low
income, under- and uninsured populations in Dallas, TX. The IRB committees of both Southern
Methodist University and the University of Texas Southwestern approved the study. Informed
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consent was obtained from all participants, and participants were compensated with a $5 gift
card for completion of the survey.
Eligibility Criteria. Parents of eligible patients were mailed a letter inviting them to
participate and provided with a toll-free number to ask questions or refuse participation.
Invitation letters were sent in English or Spanish based on preferred language listed in the EHR.
Bilingual research assistants then called parents of eligible patients, explained the project, and
asked them to report their decision stage about the vaccine. Decision stage was assessed with a
single item, “Which of the following best describes your thoughts about getting the HPV vaccine
for your [daughter/son]?” Responses options included: (1) I have never thought about getting
the HPV vaccine for him/her, (2) I am undecided about getting the HPV vaccine for [her/him],
(3) I do not want to get the HPV vaccine for [her/him], and (4) I do want to get the HPV vaccine
for [her/him]. Parents in the first two stages (i.e., never thought about the vaccine, undecided)
were invited and consented. The research assistant then administered the baseline survey over the
telephone.
Measures
Participants responded to the measures below on a 5-point Likert scale with answers
ranging from (1) strongly agree to (5) strongly disagree. Scales were reversed such that higher
values represented stronger agreement to simplify interpretation of analyses. Thus (1)
represented strongly disagree and (5) represented strongly agree. Items were averaged within
each scale to create mean scores. All items were adapted from previous research and displayed
adequate reliability. Descriptive information for all items and constructs is displayed in Table 2.
Motivation. Motivation was assessed with the Treatment Self-Regulation Questionnaire
(TSRQ), a well-validated measure of motivation in health behavior (Levesque et al., 2007),
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which has been successfully modified for application to HPV vaccination (Denman et al., 2016).
The modified TSRQ consists of eight items assessing the different types of motivation. The stem
for the eight items was “The reason you would get [child’s name] the vaccine is because…”.
Items reflected three different types of motivation along the continuum. Four items represented
autonomous motivation— e.g., “…because it is consistent with your goals as a parent.” Two
items represented introjected motivation— e.g., “you would feel guilty or ashamed if you did
not.” Two items represented external motivation— e.g., “you feel pressure from others to do
so.” Responses within the three subscales were averaged to create mean scores for each scale.
Self-Efficacy. Self-efficacy was assessed with two items reflecting participants'
confidence in their ability to get their child the vaccine in the face of barriers [e.g., "You are
confident that you can get the HPV vaccine for your child even if it means going to the clinic
three times” (Gerend & Shepherd, 2012)].
Intentions to Vaccinate. Intentions were assessed with three items asking about the
likelihood of parents vaccinating their children [e.g. “In the next year, how likely is it that you
will get the HPV vaccine for your child?” (Gerend & Shepherd, 2012)].
Subjective Norms. Subjective norms were assessed with eight items that reflected the
influence of friends and family in decision-making about the vaccine [e.g., "Your friends
influence your decision about getting your child the HPV vaccine") (Allen et al., 2009; Gerend &
Shepherd, 2012)].
Attitudes. Attitudes were assessed with six items that assessed parent’s beliefs regarding
the positive nature of HPV vaccination for their adolescents [e.g. “Getting my child the HPV
vaccine could save my child’s life” (Bynum et al., 2013; Gerend & Barley, 2009)].
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Vaccination Behavior Outcomes. An electronic health record data pull on medical
procedure codes matching administration of doses for the HPV vaccine yielded information on
vaccination status, the number of received doses, and dates of vaccination one year after the date
of randomization into the study. Vaccine initiation was operationalized as one-dose coverage
(i.e., receipt of one or more doses of the vaccine within the 12-month study period). Thus, coding
for one-dose coverage was inclusive of individuals who later received doses two and three of the
vaccine. Vaccine completion was operationalized as three-dose coverage (i.e., receipt of 3 doses
of the vaccine within the study period). I also examined a broader definition of coverage—up-todate status- to determine the influence that changes in ACIP guidelines might have on the
relationship between motivation and vaccination behavior.
One-Dose Coverage. One-dose coverage was coded as a dichotomous variable—
individuals with 1 or more dose of the vaccine in their health record were given a 1 (N= 65), and
those without a vaccine dose received a 0. Thus, one-dose coverage included individuals who
also received doses two and three of the vaccine.
Three-Dose Coverage. Three-dose coverage was coded as a dichotomous variable—
individuals with three doses of the vaccine were given a 1 (N= 27), and those with < 3 doses
were given a 0.
Up-to-Date Coverage. Up-to-date coverage was conceptualized as a less-stringent
definition of completion than three-dose coverage and counted individuals as having completed
the vaccine series if they met the ACIP's new recommendations (Robinson et al., 2018).
Adolescents were considered to be up-to-date if they had received three doses over the 12-month
study period, or if they had received two doses and the first dose was received before age 15, and
the lag between doses 1 and 2 was at least six months. Up-to-date coverage was coded as a
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dichotomous variable—individuals who were up-to-date were given a 1 (N= 30), and those who
had not met the new ACIP criteria or received three doses received a 0. Thus, coding for up-todate coverage included all individuals who counted in three-dose coverage as well as individuals
who had completed based on the new guidelines (N= 3).
Analytic Approach
Analyses were conducted using IBM SPSS version 22 and MPlus version 8 software
(Muthén & Muthén, 2012). Before data analysis, descriptive statistics were run on study
variables (Table 1). Chi-square analyses were completed to determine group differences in
predictors by parent's preferred language, adolescent age, and adolescent sex. Additionally, I
tested for differences between clinics. As data were drawn from a larger study to develop a tablet
intervention to promote HPV vaccination, some participants (n = 35) were exposed to the
intervention materials. Additionally, participants (n = 92) recruited for a different arm of the
study were recruited based on an impending doctor's visit. These factors might have impacted
vaccination rates. To account for these differences and other differences based on
sociodemographic variables, all regression analyses controlled for recruitment arm, preferred
language, adolescent age, and adolescent sex. There were no significant differences by clinic (p>
.05), so this variable was not included as a covariate in analyses.
Motivation Predicting HPV Vaccine Coverage.
Logistic Regression Models.
To determine whether autonomous, introjected and external motivation predicted the
likelihood of one-dose coverage and three-dose coverage, I conducted multivariable (including
autonomous, introjected, and external motivation as predictors) logistic regression models for
each outcome. Because changes in ACIP guidelines might impact the relationship between
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motivation and vaccine completion, I conducted an additional multivariable logistic regression
models predicting the likelihood of up-to-date coverage.
Ordinal Regression Models.
To determine the influence of the different types of motivation on overall HPV vaccine
coverage, I also conducted ordinal (proportional odds) regression analyses. Ordinal regression
analyses predict the increased likelihood of an outcome that contains three or more ordered
categories (e.g., receipt of dose two following receipt of dose one and receipt of dose three
following receipt of the first two doses), based upon a one-unit change in the predictor. Ordinal
regression is preferred to logistic regression models when the outcome has multiple categories as
it preserves the information across categories that is lost when the outcome is "dichotomized"
and when the distance between ordered categories is not equal. In the example of HPV
vaccination, there are multiple transitions between doses (i.e., from 0 to 1 dose, 1 dose to 2
doses, and 2 doses to 3 doses) and these transitions between doses vary in terms of time and
effort (e.g., returning to the clinic for more doses outside of the annual visit schedule). Ordinal
regression models assume the effect of the predictors is consistent across categories (the
assumption of proportional odds) and thus provide an estimate of the overall effect of the
predictors on the outcome. A multivariable ordinal regression was conducted to determine the
effects of autonomous, introjected, and external motivation on vaccination behavior (i.e., receipt
of zero, one, two, or three doses).
Competitive Hypothesis Testing of Direct and Indirect Paths.
To determine whether the effect of autonomous motivation on intentions to vaccinate
and vaccination behavior is direct or indirect, I used a competitive hypothesis testing strategy. I
compared nested models comprising the competing hypotheses of direct and indirect effects of
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autonomous motivation on intentions and vaccination based on chi-square difference tests. Using
SDT and the IBC model as guides, I fit the following three models separately for each outcome
as described in research questions 3 and 4: 1) a model with both direct and indirect pathways, 2)
a model with only indirect pathways, 3) and a model with only direct pathways. Structural
equation modeling was performed in MPlus version 8. For analyses predicting intentions to
vaccinate, I used a maximum likelihood (ML) estimator. For analyses in which one-dose
coverage was the outcome, I used a weighted least squares means and variance adjusted
estimator (WLSMV) for modeling purposes to account for the dichotomous outcome and nonnormally distributed predictors (Kline, 2016). Latent factors were estimated for all constructs,
and a measurement model was estimated. All factor loadings for latent variables were significant
(ps < .001) and coefficient alpha was acceptable for all scales (Table 2).
The model with only direct pathways and the model with only indirect pathways were
nested within the model with both direct and indirect pathways. These nested models allow for
comparisons to determine whether both direct and indirect paths are necessary to maintain model
fit. If model fit is reduced when comparing the model with both direct and indirect pathways to
the model with only direct pathways, the indirect pathway is needed. If model fit is not reduced,
according to the principle of parsimony, the indirect pathway can be removed (Raykov &
Marcoulides, 1999). For research question 3 (Does autonomous motivation a) directly influence
intentions to vaccinate or b) indirectly influence intentions via attitudes, norms, and selfefficacy?), my first model with both direct and indirect effects (as shown in Figure 1)
hypothesized a direct path from autonomous motivation to vaccine intentions and three indirect
paths via attitudes, self-efficacy, and norms. My second model included only the direct path from
autonomous motivation to vaccine intentions (c1), and my third model included only indirect
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effects with the three pathways to intentions via self-efficacy, attitudes, and norms (a1 x b1, a2 x
b2, a3 x b3). Parameter estimates are interpreted as regression coefficients.
For research question 4 (Does autonomous motivation a) directly influence one-dose
coverage, or b) indirectly influence initiation via intentions?), my first model with direct and
indirect effects (as shown in Figure 2) hypothesized a direct path from autonomous motivation to
one-dose coverage and an indirect path via intentions (Fig 2). My second model included only
the direct path from autonomous motivation to one-dose coverage (c1), and my third model
included only the indirect effect with the pathway from autonomous motivation to one-dose
coverage via intentions (a1 x b1).
To determine which model best fit the data within each hypothesis, I compared models
by calculating the c2 difference test statistic. A significant difference test statistic indicates the
hypothesized model with the lower chi-square value fits the data better. A nonsignificant statistic
suggests the more parsimonious model is best (Raykov & Marcoulides, 1999). The informal
model fit was also assessed by computing the comparative fit index (CFI; values between .90 and
.95 indicate adequate fit), root-mean-square error of approximation (RMSEA; values < .08
indicate adequate fit and values < .06 indicate good fit), and chi-square values (Kline, 2016).
Results
Participant Characteristics
Demographics for parent participants and their adolescent are presented in Table 1. There
were no significant differences in motivation (autonomous, introjected, or external) across
recruitment arm or adolescent gender (ps > .05). However, Spanish-speakers demonstrated
significantly higher levels of autonomous and introjected motivation (ps <.001). No significant
differences by language were evident in external motivation (p = .09). Additionally, chi-square
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analyses indicated significant differences in one-dose coverage based on recruitment arm and
parent-preferred language. Spanish speakers were more likely to initiate the vaccine series than
English-speakers (p =.03). Moreover, there was a trend for adolescent gender to suggest that
parents of adolescent females were more likely to initiate the vaccine than parents of adolescent
males (p = .06). Independent samples t-tests were examined to determine differences in one-dose
coverage by age. Younger adolescents were more likely to initiate the vaccine series (p < .001).
To control for these differences, all regression models included adolescent age, gender, parent
preferred language, and recruitment arm as covariates.
Motivation Predicting HPV Vaccine Coverage
Logistic Regression Models.
Autonomous motivation was associated with increased odds of one-dose coverage (i.e.,
receipt of one or more doses) in a multivariable, logistic regression model (OR = 2.47; 95%CI:
[1.202, 5.079], p = .01). As predicted, neither introjected nor external motivation showed a
significant effect in predicting one-dose coverage (Table 3). In a multivariable logistic regression
model predicting three-dose coverage (i.e., receipt of three doses), greater autonomous
motivation predicted three-dose coverage (OR = 2.68; 95%CI: [1. 00, 7.18], p = .05), but neither
introjected, nor external motivation showed significant influence on three-dose coverage (ps >
.05; Table 3). However, in a multivariable logistic regression model predicting up-to-date
coverage, there were no significant effects of autonomous, introjected, or external motivation (ps
> .05; Table 3). So, autonomous motivation predicted greater likelihood of vaccine initiation and
completion (receipt of three doses), but there were no significant predictors of up-to-date
coverage.
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Ordinal Regression Models.
A cumulative odds ordinal logistic regression with proportional odds was conducted to
determine the effects of the three different types of motivation on vaccination behavior (Table 4).
The assumption of proportional odds was met, as assessed by a full likelihood ratio test
comparing the fit of the proportional odds model to a model with varying location parameters,
(p= .27). This indicates the influence of autonomous motivation was consistent across each
transition between doses. An increase in autonomous motivation was significantly associated
with greater odds of overall HPV vaccine coverage (OR = 2.452, 95% CI = 1.257, 4.786, p =
.009). However, consistent with logistic regression models, there were no significant
associations between introjected and external motivation and HPV vaccine coverage (ps > .05).
Consequently, results are indicative of a positive association between autonomous motivation
and overall HPV vaccine coverage.
Competitive Hypothesis Testing of Direct and Indirect Paths
A measurement model with all latent constructs was estimated. All factor loadings were
significant, and the measurement model displayed adequate fit (c2=223.10; CFI= .935; RMSEA=
.058, 90% CI = .043, .072). Bivariate correlations between all latent constructs are displayed in
Table 5.
When I examined the effect of motivation on intentions, the model with both direct and
indirect pathways (see Figure 3) fit the data better than both the model with only indirect
pathways from autonomous motivation to intentions (c2 difference = 6.697, p = .01;
Supplementary Figure 1) and the model with only direct pathways to intentions (c2 difference =
86.194, p <.001; Supplementary Figure 2), suggesting both direct and indirect paths to
intentions. Model comparisons are displayed in Table 6. Of note, the presence of both direct and
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indirect pathways from autonomous motivation to intentions is contrary to the IBC, which
proposed only indirect paths from autonomous motivation to intentions. Significant predictors of
intentions included attitudes (standardized coefficient .32) and autonomous motivation (.39).
Autonomous motivation showed significant associations with self-efficacy (.29), attitudes (.76),
and subjective norms (.37). The indirect path from autonomous motivation to intentions via
attitudes (.25) was also significant. Self-efficacy and subjective norms were not significantly
associated with intentions to vaccinate (Figure 3). Thus, only an indirect effect of autonomous
motivation through attitudes towards vaccination was evident.
Examination of regression coefficients in the model with only indirect paths (See
Supplementary Figure 1) and the model with only direct paths (Supplementary Figure 2)
confirmed that across all three models, neither self-efficacy nor subjective norms showed
significant associations with intentions. Within the model with only indirect paths, autonomous
motivation showed significant associations with self-efficacy (.29), attitudes (.79), and subjective
norms (.36) and the indirect path between autonomous motivation and intentions via attitudes
was significant (.54, p<.001). Within the model with only direct paths (Supplementary Figure 2),
both autonomous motivation and attitudes showed significant associations with intentions (.43,
p< .001 and .41, p=.002, respectively).
Attempts to estimate models describing the effect of autonomous motivation on
vaccination behavior were adversely impacted by small sample size and, consequently,
demonstrated poor fit. Compared to analyses using maximum likelihood estimators, models
using weighted least squares means with variance adjustment (WLSMV) are less efficient and
require larger sample size to achieve adequate power. Bandalos (2014) showed that with small
samples sizes (less than 200) power for WLSMV estimation is often low and standard error bias
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is high, but that as sample size increased error rates decreased and approached a nominal rate
around a sample size of 500. Thus, these models were not deemed to be reliable and were not
interpreted. Consequently, a determination of whether autonomous motivation has a direct, or
indirect, effect on one-dose coverage could not be made at this time.
Discussion
Although motivation has been applied to numerous health behaviors, this research is
some of the first to examine the effects of motivation in the context of HPV vaccination.
Consistent with predictions based on Self-Determination Theory, these results suggest greater
autonomous motivation, rather than introjected or external motivation, is associated with
increased likelihood of both one- and three-dose coverage of the HPV vaccine. Thus, these
findings strongly suggest that, for HPV vaccination, different types of motivation are important
in parents’ decisions to vaccinate. Many past studies have demonstrated the importance of
autonomous motivation in predicting health behavior performance (Howard et al., 2017; Ng et
al., 2012). These findings support the application of autonomous motivation to HPV vaccination
behavior. Moreover, these findings clarify the pathways linking autonomous motivation to
intentions to vaccinate.
Autonomous motivation was associated with HPV vaccine initiation; with increases in
autonomous motivation, individuals had 2.5 times greater odds of receiving one or more doses of
the vaccine. Moreover, greater autonomous motivation was associated with increased odds of
three-dose coverage. I also conducted analyses investigating the impact of a different definition
of completion (i.e., up-to-date coverage). I found the influence of autonomous motivation was
less apparent when this less stringent definition of completion was applied. Given the modest
effect of autonomous motivation on three-dose coverage, this decreased effect with a less
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stringent definition of completion is likely related to an increase in “noise” in the relationship
after recording those who received only two doses but met the ACIP guidelines as having
"completed" the vaccine series (N=3). This may have resulted from lower levels of autonomous
motivation among these parents relative to parents who received all three doses of the vaccine
for their children. However, despite the lack of statistically significant influence of autonomous
motivation on up-to-date coverage, across both models of completion (i.e., three-dose coverage
and up-to-date coverage), increases in autonomous motivation were associated with nearly
doubled odds of completing the vaccine series.
Despite the mixed results for completion, examination of ordinal regression models
provides a clearer picture of the overall effect of autonomous motivation across doses. The effect
of autonomous motivation was consistent at each threshold between doses (e.g., receipt of dose
two following receipt of dose one and receipt of dose three following receipt of the first two
doses) and results indicated higher autonomous motivation was associated with 2.5 times greater
likelihood of parents electing to pursue HPV vaccine completion. Thus, with each unit-increase
in autonomous motivation, parents were more likely to get their child the vaccine (across all
doses). Such analyses are not standard in the vaccination literature, where standard practice is to
examine logistic regression models. However, application of an ordinal regression model
provided an estimate of the overall influence of autonomous motivation on decisions to
vaccinate.
Collectively, these findings strongly suggest that autonomous motivation is a vital factor
in decisions to initiate and complete the vaccine series. A recent meta-analysis stressed the
distinction between quality and quantity of motivation (Howard, Gagné, & Bureau, 2017). The
authors highlighted the importance of having autonomous reasons for engaging in the behavior,
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rather than having a higher amount of overall motivation (e.g., the amount of both controlled and
autonomous motivation). These results support this distinction and suggest only autonomous
motivation was predictive of vaccination behavior.
Analyses also revealed differences in vaccination rates by sociodemographic
characteristics. Results of descriptive analyses of the sample showed that younger adolescents
were more likely to have initiated the vaccine series than older adolescents. Moreover, there was
a trend to suggest females were more likely to meet criteria for one-dose coverage than males.
Findings that younger adolescents and females are more likely to be vaccinated are consistent
with previous studies (Bhatta & Phillips, 2015; Cowburn et al., 2014; Klosky et al., 2015;
Rahman et al., 2015) and suggest that efforts to promote catch-up vaccination (vaccination after
the target years of 11-12) among males and females, and vaccination more broadly among males,
are necessary. Notably, vaccine recommendations typically focus on younger adolescents and
preteens. Many parents indicate that they wish to wait to vaccinate until their child is older, but
providers may fail to follow up with parents in later years, and older adolescents may have
greater influence and input in the decision to obtain the vaccine than preteens. Furthermore, low
vaccination rates among males may be related to the initial recommendations and marketing for
the vaccine, which targeted females and highlighted benefits of the vaccine for female health
(i.e., cervical cancer protection) and failed to discuss the benefits for males.
The sample consisted of parents and adolescents treated at safety-net clinics.
Consequently, the majority of the sample consisted of racial and ethnic minority parents with
low education and low literacy. Additionally, more than half of the sample was Spanishspeaking. Previous work examining HPV vaccination has found that vaccination rates are lowest
among minority adolescents (Holman et al., 2014). Among this sample, Spanish-speaking
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parents had higher autonomous motivation and were more likely to vaccinate their children than
English-speaking parents. This finding is consistent with previous work showing Hispanic girls
living in predominantly Hispanic communities had higher rates of HPV vaccine initiation
compared to Hispanic girls living in majority Non-Hispanic White or Black communities (Henry
et al., 2016). Additionally, past HPV vaccine studies have shown differences in vaccination rates
between Spanish-speakers and English-speakers (Baldwin, Bruce, & Tiro, 2013; Stevens et al.,
2013). Previous work examining differential vaccination rates suggests that Hispanic individuals
with lower levels of acculturation are more supportive of vaccination for children than
individuals from other groups (Anderson et al. 1997, Henry et al., 2016). Some literature
suggests these differences may be due to a lower sense of parental responsibility for vaccination
among more highly acculturated parents (Prislin et al., 1998). For parents with a lower sense of
parental responsibility, autonomy-supportive communication may address may be beneficial in
eliciting more salient parental values and supporting more autonomously motivating perspectives
(Williams et al., 2006).
The present study also compared competing hypotheses for the paths by which
autonomous motivation influences intentions to vaccinate and vaccination behavior. This
competitive testing strategy was selected as it would allow for the comparison of areas where
Self-Determination Theory and the Integrated Behavior Change model differ in their predictions
regarding the role of autonomous motivation and its specific mechanisms of action on behavior.
While Self-Determination Theory suggests a direct effect of autonomous motivation on behavior,
the Integrated Behavior Change model purports only indirect effects of autonomous motivation
on both intentions and behavior. Findings supported the presence of both direct and indirect
pathways between autonomous motivation and intentions to vaccinate suggesting that one
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mechanism by which autonomous motivation impacts behavior may be via intentions. Contrary
to the IBC model, rather than indirect effects of autonomous motivation via attitudes, norms, and
self-efficacy, only an indirect effect through attitudes was evident. Additionally, while
autonomous motivation was related to both self-efficacy and subjective norms I found that selfefficacy and norms were not associated with intentions to vaccinate. This finding contrasts with
previous work suggesting positive associations between self-efficacy, norms, and intentions
(Gerend & Shepherd, 2012). This may be due to measurement issues as both self-efficacy and
subjective norms demonstrated the lowest reliability of all measures (a=.71 for both constructs).
Alternatively, the lack of significant associations between self-efficacy, norms, and intentions
may be related to the sample of undecided parents. Among parents who are ambivalent about the
vaccine, there may be less reliable relationships between perceptions of ability to get the vaccine,
the perceived importance of others’ opinions on vaccination, and intentions to vaccinate. Parents’
perceptions around the opinions of others and their own ability to get the vaccine may be less
established or less meaningful in the context of ambivalence. In broader samples that include
parents at all levels of vaccine decision-making, self-efficacy and norms might demonstrate
significant associations with intentions to vaccinate, the indirect effects through self-efficacy and
norms proposed in the IBC model could be evident. Collectively, results suggest that
autonomous motivation is an essential predictor of intentions to vaccinate and consideration of
autonomous motivation in the context of its effects on attitudes and intentions may be beneficial.
While findings of both direct and indirect effects of autonomous motivation on intentions
contrast with the predictions of the Integrated Behavior Change model, the implications suggest
that intervening to increase autonomous motivation may be a feasible method of changing
attitudes and increasing intentions to vaccinate. Future research should clarify the presence of
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indirect effects through self-efficacy and norms using more reliable measures and tests
interventions targeting autonomous motivation as a means of promoting vaccination by changing
attitudes about vaccination.
The paths by which autonomous motivation influence vaccination behavior remain
unclear. Low power compromised model estimation examining the effects of autonomous
motivation on vaccination behavior and these models were not interpreted at this time. While
WLMSV is considered the best estimator for models with dichotomous outcomes, it is less
efficient than maximum likelihood estimation, uses pairwise deletion, and typically requires
larger sample sizes than models estimated with maximum likelihood (Bandalos, 2014). Thus, in
addition to low power, missing data across predictors potentially impacted ability to estimate the
model successfully. Given the paucity of studies examining the influence of autonomous
motivation on vaccination behavior, future studies with larger sample sizes should test the direct
paths between autonomous motivation and vaccination behavior to elucidate the mechanisms by
which autonomous motivation influences vaccination. The potential presence of a direct effect of
autonomous motivation on behavior highlights the importance of identifying interventions to
increase autonomous motivation.
Self-Determination Theory suggests that internalization of values is the mechanism of
change for humans (Ryan & Deci, 1985; Williams et al., 2006). SDT-guided interventions have
proven effective in increasing performance of other health behaviors that require repeated
behavior performance (Williams et al., 2006). While such interventions have not been tested in
the context of HPV vaccination, these findings support the utility of SDT-guided interventions to
promote HPV vaccination.
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Prior work to increase autonomous motivation for health outcomes has targeted
autonomy support to facilitate autonomous motivation and competence (Ryan, Patrick, Deci, &
Williams, 2008; Williams et al., 2006; Williams, Cox, et al., 1999; Williams & Deci, 2001;
Williams et al., 1996; Williams et al., 1998). Autonomy support involves providing relevant
information and soliciting choice, eliciting peoples' perspectives, and minimizing pressure
(Williams et al., 2006). Thus, developing interventions targeting doctor’s recommendations may
be a useful means of intervening to increase autonomous motivation.
Doctor's recommendation is frequently cited as a critical predictor of vaccination (Bhatta
& Phillips, 2015; Gilkey et al., 2016; Holman et al., 2014; Klosky et al., 2015). Currently, the
CDC recommends “presumptive” provider recommendations for the HPV vaccine—assuming
parents will decide in favor of vaccination—rather than participatory recommendations that
allow for leeway (Opel et al. 2013; Shay et al. 2016). For some parents, however, a presumptive
recommendation is not sufficient due to ambivalence or concerns about the vaccine. For these
parents, an autonomy-supportive recommendation may be better suited to the promotion of
decisions to vaccinate. Efforts to increase patient-centered care and autonomy-supportive
recommendations may lead to increased autonomous motivation and vaccination behavior by
acknowledging and addressing parents’ concerns and priorities for their children’s health. Use of
an autonomy-supportive approach would also highlight the benefits of the vaccine, and thus
foster autonomous motivation by helping parents understand the importance of the vaccine.
Motivational interviewing (MI) also holds promise as a means of facilitating autonomous
motivation among parents who remain ambivalent after receiving a recommendation.
Motivational interviewing was initially developed in the addiction treatment field as a means of
facilitating health behavior performance and is a style of communication that emphasizes
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reflective listening, eliciting change talk, and shared decision-making (Rollnick, Miller, &
Butler, 2008). The goal of motivational interviewing is often to work through ambivalence or
resistance to behavior and MI has been applied to the promotion of several health behaviors
(Dunn, Deroo, & Rivara, 2001). A recent intervention targeting provider communication
supported the implementation of motivational interviewing with parents who were resistant to
the vaccine and showed significantly higher HPV vaccine series initiation and completion
(Dempsey et al., 2018). Future studies should build on these findings and develop interventions
targeting parental motivation through autonomy-supportive communication styles and provision
of information targeted to parents’ concerns.
This study has several strengths. First, this data was longitudinal and allowed for the
examination of the association between baseline motivation and subsequent vaccination
behavior. Additionally, though the majority of studies on HPV vaccination behavior focus on
initiation, with longitudinal data, I was able to examine completion of the vaccine series.
Moreover, the use of structural equation modeling for competitive hypothesis testing facilitated a
more stringent estimation of effects as well as the isolation of competing arguments (i.e., indirect
vs. direct pathways from autonomous motivation to intentions to vaccinate; Brewer & Gilkey,
2012). To date, competitive hypothesis testing has not been applied to the pathways linking
autonomous motivation to intentions and behavior as proposed in the Integrated Behavior
Change model (Hagger & Chatzisarantis, 2009; 2014). However, this method holds promise for
enhancing understanding of the mechanisms of change for autonomous motivation and the
advancement of theory.
This study does have some limitations. First, the sample was restricted to parents who
had never heard of the HPV vaccine or were undecided about vaccination. This limits
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generalizability of these findings as parents who had decided for, or against, the vaccine were
excluded. For parents who had already decided to vaccinate their adolescents, we might expect to
see high levels of autonomous motivation. For parents who previously decided not to vaccinate
their children, however, the underlying motivations are less predictable. For example, parents
with negative perceptions about the HPV vaccine may report low levels of all types of
motivation. Alternatively, parents with negative perceptions of the vaccine may be autonomously
motivated against vaccination. Understanding the motivation underlying decisions not to
vaccinate may be beneficial in promoting vaccination among parents who are ambivalent or
resistant to vaccination. A related limitation of this study is the lack data on parental vaccine
hesitancy and amotivation. According to Self-Determination Theory, amotivation is the lack of
motivation to perform a behavior (Levesque et al., 2007). For some parents, amotivation and
hesitancy may lead to decisions to delay the vaccine series until their child is older. Future
studies should examine parents at all stages of decision-making and assess amotivation and
vaccine hesitancy to understand how these constructs relate to refusal and delay of the vaccine. A
further limitation of the study was the relatively small sample size, which was problematic in
structural equation models examining one-dose coverage where sample size suggestions range
from 200-500 when using a WLMSV estimator for dichotomous outcomes (Bandalos, 2014).
Future research should examine direct and indirect pathways in larger samples that may allow for
more accurate estimation of effects. Moreover, the relatively short time frame for follow up (i.e.,
twelve months) was a limitation of this study. While the twelve-month time frame can be
considered sufficient for completion based on the recommended vaccine schedule, few parents
are sticking to this timeline. Practically, the majority of parents vaccinate their children during
their annual, well-child visits (Dempsey et al., 2018; Dempsey, Abraham, Dalton, & Ruffin,
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2009). Moreover, there is no evidence to suggest that completion on the recommended schedule
is needed to maintain efficacy of the vaccine, so there is little incentive for parents or providers
to adhere to the recommended dosing schedule. Examination of the overall rates of vaccination
in Dallas County for 2016 reveals they are higher than rates in this study population (45.7% of
adolescents had one-dose coverage, and 23.9% of adolescents had up-to-date coverage in 2016;
Walker et al., 2017) and suggest that with more time, rates of adolescent vaccination would
likely continue to rise. Thus, it is likely that with increased time for follow-up (e.g., two years) I
would see an increased frequency of completion, and a stronger influence of autonomous
motivation.
Although I had temporal precedence of behavior, all predictors were measured at the
same time and are correlational. This limits the ability to draw conclusions about the indirect
versus direct effects of autonomous motivation on intentions. A future study assessing the
indirect and direct effects of autonomous motivation on intentions measured at a later time or on
behavior would provide a better estimation of these effects (Maxwell, Cole, & Mitchell, 2011).
Finally, the sample consists of individuals receiving care in safety net clinics. Low education,
low health literacy, and low socioeconomic status overall characterize the sample as almost all
patients seen at these clinics are under- or un-insured. It is possible that parents of higher
education and SES might have other factors that impact vaccine decision-making and thus
findings may not generalize to other populations.
Conclusions
These findings suggest that autonomous motivation predicts a higher likelihood of HPV
vaccine coverage. Additionally, findings from this study support the concept that the quality of
motivation is critical in promoting behavior as neither introjected nor external motivation
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showed any significant effect on vaccination behavior. Consequently, these findings support the
utility of providing autonomy-supportive interventions.
Results also suggest that considering autonomous motivation in the context of attitudes
toward vaccination and intentions to vaccinate may be beneficial to facilitating understanding of
the mechanisms by which it impacts behavior. Autonomous motivation was found to have both a
significant indirect effect via attitudes and a direct effect on intentions to vaccinate. This
suggests that autonomous motivation leads to the development of more positive attitudes and
influences behavior through the internalization of beliefs as posited by the Self-Determination
Theory. These findings provide a foundation upon which future research can expand through the
development of autonomy supportive interventions to increase HPV vaccination.
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Table 1. Participant Characteristics
Autonomous Motivation
Introjected Motivation
External Motivation

Mean (SD)
4.11 (.57)
2.93 (1.09)
1.97 (.72)
N

Range
2-5
1-5
1-4.5
%

Vaccination Rates
One-Dose Coverage
65
36.7
Three-Dose Coverage
27
15.3
Up-To-Date Coverage
30
16.9
Parent Sex
Female
172
97.2
Male
5
2.8
Parent Language
Spanish
104
58.8
English
73
41.2
Parent Age
20-29
3
1.7
30-39
96
54.2
40-49
60
33.9
50 or older
18
10.2
Parent Race/Ethnicity
Hispanic
122
68.9
Non-Hispanic Black
50
28.2
Non-Hispanic White
4
2.3
Unknown race/ethnicity
1
0.6
Parent Education
Less than high school
37
20.9
Some high school
37
20.9
High school/Vocational degree
61
34.5
Some college/College graduate
42
23.7
Adolescent Sex
Male
93
52.5
Female
84
47.5
Adolescent Age
11-12
88
49.7
13-14
47
26.6
15-17
42
23.7
Adolescent Race/Ethnicity
Hispanic
119
67.2
Non-Hispanic Black
48
27.1
Non-Hispanic White
4
2.3
Unknown race/ethnicity
6
3.4
*Survey responses ranged from (1) strongly disagree to (5) strongly agree, thus higher values
represent higher motivation.
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Table 2. Factor Loadings Across All Latent Constructs
Construct
Autonomous Motivation (a=.82)
The reason you would get [child’s name here] the vaccine is because you want to take responsibility for
your child’s health.
The reason you would get [child’s name here] the vaccine is because it is important.
The reason you would get [child’s name here] the vaccine is because it is consistent with your goals as a
parent.
The reason you would get [child’s name here] the vaccine is because you believe it is the best thing for
your child.
Introjected Motivation (a=.75)
The reason you would get [child’s name here] the vaccine is because you would feel guilty or ashamed if
you did NOT.
The reason you would get [child’s name here] the vaccine is because you would feel bad about yourself if
you did NOT.
External Motivation (a=.79)
The reason you would get [child’s name here] the vaccine is because others would be upset with you if you
did NOT.
The reason you would get [child’s name here] the vaccine is because you feel pressure from others to do
so.
Intentions (a=.87)
In the next year, how likely is it that you will think about getting the HPV vaccine for [child’s name here]?
In the next year, how likely is it that you will get the HPV vaccine for [child’s name here]?
In the next year, if a doctor or nurse at the clinic recommends the HPV vaccine for [child’s name here],
how likely is it that you would get [child’s name here] the vaccine?
Self-Efficacy (a=.71)
You are confident that you can get the HPV vaccine for [child’s name here].
You are confident that you can get the HPV vaccine for [child’s name here], even if it means going to the
clinic three times.

Loading

p

.546

<.001

.823
.723

<.001
<.001

.814

<.001

.75

<.001

.80

<.001

.82

<.001

.81

<.001

.744
.878
.829

<.001
<.001
<.001

.735

<.001

.759

<.001
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Attitudes (a=.81)
Getting my child the HPV vaccine will be good for my child’s health.
Other parents in my community are getting their children the HPV vaccine.
Getting the HPV vaccine could save my child’s life.
The HPV vaccine was well tested before being made available to the public.
The benefits of having my child get the HPV vaccine are greater than the risks related to getting the
vaccine.
Getting the HPV vaccine will give me peace of mind about my child’s health.
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.803
.382
.705
.664
.577

<.001
<.001
<.001
<.001
<.001

.779

<.001

Norms (a=.71)
Your spouse or partner influences your decision about getting [child’s name here] the HPV vaccine.
Your family influences your decision about getting [child’s name here] the HPV vaccine.

.668
.660

<.001
<.001

Your friends influence your decision about getting [child’s name here] the HPV vaccine.
Your child’s doctor or nurse influences your decision about getting [child’s name here] the HPV vaccine.

.402
.524

<.001
<.001
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Table 3. Logistic Regression Models
Model
B

S.E.

Wald

p

Exp(B)

CI 95%

Motivation Predicting
One-Dose Coverage
Autonomous Motivation

.866

.411

4.442

.035

2.378

1.063 - 5.320

Introjected Motivation

.197

.186

1.125

.289

1.218

.846 - 1.752

External Motivation

.019

.280

.005

.945

1.020

.589 - 1.765

Autonomous Motivation

1.310

.607

4.655

.031

3.706

1.127 - 12.182

Introjected Motivation

.124

.255

.237

.626

1.132

.687 - 1.868

External Motivation

.557

.368

2.295

.130

1.745

.849 - 3.587

Autonomous Motivation

.834

.544

2.349

.125

2.302

.793 - 6.687

Introjected Motivation

.136

.245

.308

.579

1.146

.708 - 1.853

External Motivation

.372

.360

1.066

.302

1.450

.716 – 2.93

Motivation Predicting
Three-Dose Coverage

Motivation Predicting UpTo-Date Coverage

*All regression models controlled for recruitment arm, adolescent age, adolescent sex, and
parent preferred language.
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Table 4. Ordinal Regression Models
Model
B
S.E.
Wald
p
Exp(B)
CI 95%
Autonomous Motivation
.988
.403
6.014
.014
2.686
1.219 - 5.918
Introjected Motivation
.168
.176
.908
.341
1.183
.837 - 1.671
External Motivation
.223
.264
.715
.398
1.250
.745 - 2.098
*All regression models controlled for recruitment arm, adolescent age, adolescent sex, and
parent preferred language.
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Table 5. Bivariate Correlations between Latent Variables
Construct
Attitudes
Self-Efficacy Norms
Attitudes
Self-Efficacy
Norms
Intentions
Autonomous Motivation

1
.262**
.110
.495**
.612**

1
.146
.138
.234**

1
.033
.082
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Intentions

1
.516**

Autonomous
Motivation

1
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Table 6. Fit indices for competitive model testing
Model
df
c2
Direct & Indirect Paths
223.101
140

52

CFI
.935

RMSEA
.058

CI 90%
.043 - .072

Direct Path Only

309.295

143

.869

.081

.069 - .093

Indirect Paths Only

229. 798

141

.930

.060

.045 - .073

Model Comparison
Direct & Indirect Paths vs,
Direct Path Only
Direct & Indirect Paths vs.
Indirect Paths Only

c2 difference

df difference

86.194

3

p= .000

6.697

1

p= .009

Significance testing
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Figure 1. Proposed Model with Direct and Indirect Effects for Research Question 3
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Figure 2. Proposed Model with Direct and Indirect Effects for Research Question 4
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Figure 3. Final Model with Direct and Indirect Effects for Research Question 3

Dashed lines represent nonsignificant paths. Solid lines represent significant paths.
*p < .05, ** p <.001
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Supplemental Figure 1. Final Model with only Indirect Effects

Dashed lines represent nonsignificant paths. Solid lines represent significant paths.
*p < .05, ** p <.001
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Supplemental Figure 2. Final Model with only Direct Effects

Dashed lines represent nonsignificant paths. Solid lines represent significant paths.
*p < .05, ** p <.001
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